 UTRECHT, The Netherlands and PHILADELPHIA, May 25, 2021 GLOBE NEWSWIRE -- LAVA Therapeutics N.V. Nasdaq: LVTX, a biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy, today announced that Stephen Hurly, chief executive officer, will present at the 2021 Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 11:30 a.m. ET. 